Global Bacillus Coagulans Revenue Is Nearly 16.8 M USD And The Actual Sales Are About 26 MT In 2016
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, Global market of Bacillus Coagulans developed rapidly, with an average growth rate of 9%. In 2016, Global Revenue of Bacillus Coagulans is nearly 16.8 M USD; the actual sales are about 26 MT.
The global average price of Bacillus Coagulans is in the increasing trend, from 620 USD/Kg in 2012 to 650 USD/Kg in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Bacillus Coagulans includes Below?100?B, 100-200?B and Above?200?B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.